Page 68 - Bsx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bsx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bsx Today - Breaking & Trending Today

Biogen (NASDAQ:BIIB) Price Target Raised to $320.00 at Argus

Boston Scientific Co. (NYSE:BSX – Get Rating) EVP Wendy Carruthers sold 11,671 shares of Boston Scientific stock in a transaction that occurred on Monday, April 17th. The shares were sold at an average price of $51.96, for a total transaction of $606,425.16. Following the transaction, the executive vice president now directly owns 83,373 shares in […] ....

United States , Wendy Carruthers , Moneta Group Investment Advisors , Boston Scientific Corp , Arrowstreet Capital Limited Partnership , Boston Scientific Co , Boston Scientific , Securities Exchange Commission , Norges Bank , Needham Company , Impax Asset Management Group , Morgan Stanley , Get Rating , Exchange Commission , Scientific Stock Down , Group Investment Advisors , Capital Management , Capital Limited Partnership , Asset Management Group , Boston Scientific Daily , Nyse Bsx , Insider Trading , Nsider Trades ,

HitBTC Token (HIT) Price Hits $0.15 on Top Exchanges

Shares of Boston Scientific Co. (NYSE:BSX – Get Rating) saw unusually-high trading volume on Friday . Approximately 10,359,650 shares changed hands during trading, an increase of 32% from the previous session’s volume of 7,862,722 shares.The stock last traded at $51.68 and had previously closed at $52.62. Analyst Ratings Changes Several research analysts have commented on […] ....

United States , Jeffreyb Mirviss , Stifel Nicolaus , Wendy Carruthers , Securities Exchange Commission , Boston Scientific Company Profile , Boston Scientific Corp , Householder Group Estate Retirement Specialist , Baldwin Brothers , Hazlett Burt Watson Inc , Boston Scientific , Acadian Asset Management , Boston Scientific Co , Morgan Stanley , Family Office , Get Rating , Scientific Stock Down , Exchange Commission , Group Estate , Retirement Specialist , Asset Management , Boston Scientific Daily , Nyse Bsx ,

BTIG Research Boosts Boston Scientific (NYSE:BSX) Price Target to $54.00

Boston Scientific (NYSE:BSX – Get Rating) had its price target lifted by BTIG Research from $53.00 to $54.00 in a research note released on Monday, The Fly reports. They currently have a buy rating on the medical equipment provider’s stock. Several other brokerages have also weighed in on BSX. Needham & Company LLC increased their […] ....

United States , Jeffreyb Mirviss , Stifel Nicolaus , Wendy Carruthers , International Assets Investment Management , Boston Scientific Corp , Boston Scientific , Acadian Asset Management , Prudential Plc , Needham Company , Sequoia Financial Advisors , Get Rating , Assets Investment Management , Asset Management , Investment Advisers , Boston Scientific Daily , Nyse Bsx , Boost Price Target , Btig Research ,

Boston Scientific Co. (NYSE:BSX) Shares Purchased by GAM Holding AG

GAM Holding AG grew its stake in shares of Boston Scientific Co. (NYSE:BSX – Get Rating) by 11.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,562 shares of the medical equipment provider’s stock after acquiring an additional […] ....

United States , Danielj Brennan , Raymond James , Rathbones Group Plc , Gam Holding , Boston Scientific Co , Impax Asset Management Group , Boston Scientific , Exchange Commission , Boston Scientific Corp , Vanguard Group Inc , Nuveen Asset Management , Arrowstreet Capital Limited Partnership , Get Rating , Capital Limited Partnership , Asset Management Group , Group Plc , Asset Management , Boston Scientific Daily , Nyse Bsx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

BTIG Research Increases Boston Scientific (NYSE:BSX) Price Target to $54.00

Boston Scientific (NYSE:BSX – Get Rating) had its price objective raised by equities research analysts at BTIG Research from $53.00 to $54.00 in a note issued to investors on Monday, The Fly reports. The brokerage currently has a “buy” rating on the medical equipment provider’s stock. BTIG Research’s price objective indicates a potential upside of […] ....

United States , Raymond James , Danielj Brennan , Moneta Group Investment Advisors , Artisan Partners Limited Partnership , Boston Scientific , Needham Company , Geode Capital Management , Vanguard Group Inc , Boston Scientific Corp , Get Rating , Capital Management , Zentral Genossenschafts Bank Frankfurt , Partners Limited Partnership , Group Investment Advisors , Boston Scientific Daily , Nyse Bsx , Boost Price Target , Btig Research ,